Rituximab-CHOP
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Rituximab-CHOP, covering 2020-06-02 to 2020-10-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma [Phase 2]